Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;14(1):26-30.
doi: 10.15420/icr.2018.37.1.

TAVI for Pure Native Aortic Regurgitation: Are We There Yet?

Eduardo A Arias  1 , Amit Bhan  2 , Zhan Y Lim  3 , Michael Mullen  2
Affiliations
Review

TAVI for Pure Native Aortic Regurgitation: Are We There Yet?

Eduardo A Arias et al. Interv Cardiol. 2019 Feb.

Abstract

Treatment of degenerative aortic stenosis has been transformed by transcatheter aortic valve implantation (TAVI) over the past 10-15 years. The success of various technologies has led operators to attempt to broaden the indications, and many patients with native valve aortic regurgitation have been treated 'off label' with similar techniques. However, the alterations in the structure of the valve complex in pure native aortic regurgitation are distinct to those in degenerative aortic stenosis, and there are unique challenges to be overcome by percutaneous valves. Nevertheless some promise has been shown with both non-dedicated and dedicated devices. In this article, the authors explore some of these challenges and review the current evidence base for TAVI for aortic regurgitation.

Keywords: Aortic valve stenosis; TAVI; native aortic valve regurgitation; second generation TAVI device; transcatheter valve interventions; valvular heart disease.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Main Differences Between Aortic Stenosis and Aortic Regurgitation on CT Scan
See this image and copyright information in PMC

References

    1. Perrin N, Frei A, Noble S. Transcatheter aortic valve implantation: Update in 2018. Eur J Intern Med. 2018;55:12–9. doi: 10.1016/j.ejim.2018.07.002. - DOI - PubMed
    1. Vahanian A, Alfieri O, Andreotti F et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur J Cardiothorac Surg. 2012;42:S1–44. doi: 10.1093/ejcts/ezs455. - DOI - PubMed
    1. Nishimura RA, Otto CM, Bonow RO et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70:252–89. doi: 10.1016/j.jacc.2017.03.011. - DOI - PubMed
    1. Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607. doi: 10.1056/NEJMoa1008232. - DOI - PubMed
    1. Eltchaninoff H, Prat A, Gilard M et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191–7. doi: 10.1093/eurheartj/ehq261. - DOI - PubMed